The next-generation cancer diagnostics technologies are aiding in early cancer diagnostics and prevention. Researchers are continuously taking efforts in developing new diagnostic tools for cancer as well as advancing the existing ones. Many of the market players are collaborating for the development of new cancer biomarkers and assays, thus favoring the market growth.
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements.
The global next-generation cancer diagnostics market is segmented on the basis of technology, application, cancer type, and function. Based on product the market is segmented into qPCR and multiplexing, benchtop sequencers, lab-on-a-chip, next-generation sequencing, protein microarrays, DNA microarrays, other technologies. Based on the application the market is segmented into biomarker development, proteomic analysis, CTC analysis, genetic analysis, and epigenetic analysis. Based on cancer type the market is segmented into lung cancer, colorectal cancer, breast cancer, prostate cancer, and others. The function segment is segmented into cancer screening, therapeutic monitoring, prognosis diagnostics, risk analysis, and companion diagnostics.
· Most cancers are initially recognized either because of the appearance of signs or symptoms or through screening. Neither of these leads to a definitive diagnosis, which requires the examination of a tissue sample by a pathologist. People with suspected cancer are investigated with medical tests. These commonly include blood tests, X-rays, (contrast) CT scans and endoscopy.
· The tissue diagnosis from the biopsy indicates the type of cell that is proliferating, its histological grade, genetic abnormalities and other features. Together, this information is useful to evaluate the prognosis and to choose the best treatment.
· Cytogenetics and immunohistochemistry are other types of tissue tests. These tests provide information about molecular changes (such as mutations, fusion genes and numerical chromosome changes) and may thus also indicate the prognosis and best treatment.
· Cancer diagnosis can cause psychological distress and psychosocial interventions, such as talking therapy, may help people with this.
Want to know more about Next Generation Cancer Diagnostics??? Just go through the Link –